Medicare Part D 2016 Formulary Changes Service To Senior and OC Preferred
|
|
|
- Daniel Mosley
- 5 years ago
- Views:
Transcription
1 Medicare Part D 2016 Formulary s Service To Senior and OC Preferred Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization, quantity limits and/or step therapy restrictions or move a drug to a higher cost-sharing tier, we will notify you of the change at least 60 days before the date that the change becomes effective. However, if the U.S. Food and Drug Administration (FDA) determines a drug on our formulary to be unsafe or the drug s manufacturer removes the drug from the market, we will immediately remove the drug from our formulary. The table below outlines changes made to our formulary throughout VERSION: FORMULARY S UPDATE AS OF SEPTEMBER 1, 2016: FORMULARY ID: Formulary additions, reductions in preferred or tiered cost-sharing status, or removal of to an existing formulary drug Covered Drug Name ARISTADA INJ 441MG/1. ARIPIPRAZOLE LAUROXIL 9/1/16 4 ARISTADA INJ 662MG/2 ARIPIPRAZOLE LAUROXIL 9/1/16 4 ARISTADA INJ 882MG/3 ARIPIPRAZOLE LAUROXIL 9/1/16 4 FYCOMPA SUS 0.5MG/ML PERAMPANEL 9/1/16 4 HYDROXYPROGESTERONE HYDROXY CAPR INJ 1.25/5ML CAPROATE 9/1/16 4 LENVIMA CAP 8 MG LENVATINIB 9/1/16 5 TIVICAY TAB 10MG DOLUTEGRAVIR 9/1/16 4 TIVICAY TAB 25MG DOLUTEGRAVIR 9/1/16 5 AZATHIOPRINE INJ 100MG AZATHIOPRINE 8/1/16 2 1
2 BRINTELLIX TAB 10MG VORTIOXETINE DELETED 8/1/16 0 BRINTELLIX TAB 20MG VORTIOXETINE DELETED 8/1/16 0 BRINTELLIX TAB 5MG VORTIOXETINE DELETED 8/1/16 0 BRIVIACT INJ 50MG/5ML BRIVARACETAM 8/1/16 4 BRIVIACT TAB 10MG BRIVARACETAM 8/1/16 4 BRIVIACT SOL 10MG/ML BRIVARACETAM 8/1/16 4 BRIVIACT TAB 100MG BRIVARACETAM 8/1/16 4 BRIVIACT TAB 25MG BRIVARACETAM 8/1/16 4 BRIVIACT TAB 50MG BRIVARACETAM 8/1/16 4 BRIVIACT TAB 75MG BRIVARACETAM 8/1/16 4 CABOMETYX TAB 20MG CABOMETYX TAB 40MG CABOMETYX TAB 60MG DESCOVY TAB 200/25 CABOZANTINIB CABOZANTINIB CABOZANTINIB EMTRICIABINE AND TENOFOVIR ALAFENAMIDE 8/1/16 5 8/1/16 5 8/1/16 5 8/1/16 4 ELIQUIS TAB 2.5MG APIXABAN UPDATED 8/1/16 3, QL (60 PER 30 DAYS), QL (30 PER 30 DAYS), QL (120 PER 30 DAYS), QL (60 PER 30 DAYS) 2
3 ELIQUIS TAB 5MG APIXABAN UPDATED 8/1/16 3 ELITEK INJ 7.5MG LENVIMA CAP 18MG RASBURICASE LENVATINIB 8/1/16 5 8/1/16 5 LENVIMA CAP 8MG LENVATINIB 8/1/16 5 NUPLAZID TAB 17MG PIMAVANSERIN 8/1/16 4 PROMACTA TAB 75MG ELTROMBOPAG DELETED 8/1/16 0 ROWEEPRA TAB 500MG LEVETIRACETAM 8/1/16 2 TECENTRIQ INJ 1200/20 ATEZOLIZUMAB 8/1/16 5 TIMOLOL GEL SOL 0.25% OP TIMOLOL UPDATED 8/1/16 2 TIMOLOL GEL SOL 0.5% OP TIMOLOL UPDATED 8/1/16 2 TRINTELLIX TAB 10MG VORTIOXETINE 8/1/16 4 TRINTELLIX TAB 20MG VORTIOXETINE 8/1/16 4 TRINTELLIX TAB 5MG VORTIOXETINE 8/1/16 4 EMTRICITABINE AND TENOFOVIR DISOPROXIL TRUVADA TAB FUMARATE 8/1/16 4 EMTRICITABINE AND TENOFOVIR DISOPROXIL TRUVADA TAB FUMARATE 8/1/16 4, QL (60 PER 30 DAYS), QL (90 PER 30 DAYS) 3
4 TRUVADA TAB VENCLEXTA TAB 50MG VENCLEXTA TAB 100MG VENCLEXTA TAB 10MG EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE VENETOLAX VENETOLAX VENETOLAX 8/1/16 4 8/1/16 4 8/1/16 4 8/1/16 4 VENCLEXTA TAB START PK VENETOLAX 8/1/16 4 ZAZOLE CRE 0.4% TERCONAZOLE DELETED 8/1/16 0 AMNESTEEM CAP 10MG ISOTRETINOIN DELETION 6/1/ AMNESTEEM CAP 20MG ISOTRETINOIN DELETION 6/1/ AMNESTEEM CAP 40MG ISOTRETINOIN DELETION 6/1/ AVANDAMET TAB MG ROSIGLITAZONE AND METFORMIN DELETION 6/1/16 4 QL (60 PER 30 DAYS) BENLYSTA INJ 400MG BELIMUMAB 6/1/16 5 CARBAMAZEPINE TAB 100MGER CARBAMAZEPINE 6/1/ CEFAZOLIN INJ 1GM CEFAZOLIN 6/1/16 2 CEFAZOLIN INJ 1GM CEFAZOLIN DELETION 6/1/16 2 COMVAX INJ HAEMOPHILUS B CONJUGATE AND HEPATITIS B VACCINE DELETION 6/1/
5 MOMETASONE SPR 50MCG NASONEX 6/1/16 2 QL (34 PER 30 DAYS) ODEFSEY TAB EMTRICITABINE,RILPIVIRIN E AND TENOFOVIR ALAFENAMIDE 6/1/ SPRITAM TAB 1000MG LEVETIRACETAM 6/1/ SPRITAM TAB 250MG LEVETIRACETAM 6/1/ SPRITAM TAB 500MG LEVETIRACETAM 6/1/ SPRITAM TAB 750MG LEVETIRACETAM 6/1/ VRAYLAR CAP 1.5-3MG CARIPRAZINE 6/1/ XELJANZ XR TAB 11MG TOFACITINIB 6/1/16 5 ANDROGEL GEL PUMP 1% TESTOSTERONE DELETION 05/01/16 4 QL (300 PER 30 DAYS) BIVIGAM INJ 10% IMMUNE GLOBULIN 05/01/16 5 FLEBOGAMMA INJ DIF 10% IMMUNE GLOBULIN 05/01/16 5 FLUCONAZOLE/ INJ DEX 400 FLUCONAZOLE/ INJ DEX 05/01/16 2 FLUCONAZOLE/ INJ DEX 400 FLUCONAZOLE/ INJ DEX DELETION 05/01/16 2 GAMMAKED INJ 1GM/10ML IMMUNE GLOBULIN 05/01/16 5 GAMMAPLEX INJ 10GM IMMUNE GLOBULIN 05/01/16 5 IMATINIB MES TAB 100MG GLEEVEC 05/01/16 2 QL (90 PER 30 DAYS) IMATINIB MES TAB 400MG GLEEVEC 05/01/16 2 QL (60 PER 30 DAYS) MOLINDONE TAB HCL 10MG MOLINDONE UPDATE 05/01/16 2 MOLINDONE TAB HCL 25MG MOLINDONE UPDATE 05/01/16 2 5
6 MOLINDONE TAB HCL 5MG MOLINDONE UPDATE 05/01/16 2 OCTAGAM INJ 25GM IMMUNE GLOBULIN 05/01/16 5 OCTAGAM INJ 2GM/20ML IMMUNE GLOBULIN 05/01/16 5 OLOPATADINE DRO 0.1% PATANOL 05/01/16 2 PRIVIGEN INJ 20GRAMS IMMUNE GLOBULIN 05/01/16 5 SODIUM SULFATE, POTASSIUM SULFATE AND SUPREP BOWEL SOL PREP MAGNESIUM SULFATE 05/01/16 3 VRAYLAR CAP 1.5MG CARIPRAZINE 05/01/16 4 VRAYLAR CAP 3MG CARIPRAZINE 05/01/16 4 VRAYLAR CAP 4.5MG CARIPRAZINE 05/01/16 4 VRAYLAR CAP 6MG CARIPRAZINE 05/01/16 4 AVANDIA TAB 8MG ROSIGLITAZONE DELETION 4/1/ QL (60 PER 30 DAYS) EMPLICITI INJ 400MG 5 ELOTUZUMAB 4/1/2016 GLEOSTINE CAP 100MG LOMUSTINE 4/1/ GLEOSTINE CAP 10MG LOMUSTINE 4/1/ GLEOSTINE CAP 40MG LOMUSTINE 4/1/ INVEGA TRINZ INJ 273MG 5 PALIPERIDONE 4/1/2016 INVEGA TRINZ INJ 410MG 5 PALIPERIDONE 4/1/2016 INVEGA TRINZ INJ 546MG 5 PALIPERIDONE 4/1/2016 6
7 INVEGA TRINZ INJ 819MG 5 PALIPERIDONE 4/1/2016 LOMUSTINE CAP 100MG LOMUSTINE DELETION 4/1/ LOMUSTINE CAP 10MG LOMUSTINE DELETION 4/1/ LOMUSTINE CAP 40MG LOMUSTINE DELETION 4/1/ PHENYTOIN EX CAP 200MG DILANTIN 4/1/ PHENYTOIN EX CAP 300MG DILANTIN 4/1/ TRIAMCINOLON SPR DELETION 55MCG/AC NASACORT 4/1/ QL (33 PER 30 DAYS) VIIBRYD KIT STARTER VILAZODONE 4/1/ ABILIFY DISC TAB 10MG ARIPIPRAZOLE DELETION 3/1/ ALECENSA CAP 150MG ALECTINIB 3/1/ ALOSETRON TAB 0.5MG LOTRONEX 3/1/ ALOSETRON TAB 1MG LOTRONEX 3/1/ ARIPIPRAZOLE TAB 10MG ABILIFY 3/1/ AVASTIN INJ 400/16ML BEVACIZUMAB 3/1/ BEXAROTENE CAP 75MG TARGRETIN 3/1/2016 2, QL (90 PER 30 DAYS), QL (60 PER 30 DAYS), QL (60 PER 30 DAYS), QL (90 PER 30 DAYS) 7
8 BREO ELLIPTA INH FLUTICASONE AND VILANTEROL 3/1/ CLOZAPINE TAB 100/ODT FAZACLO 3/1/ QL (270 PER 30 DAYS) CLOZAPINE TAB 12.5/ODT FAZACLO 3/1/ QL (90 PER 30 DAYS) CLOZAPINE TAB 150/ODT FAZACLO 3/1/ QL (180 PER 30 DAYS) CLOZAPINE TAB 200/ODT FAZACLO 3/1/ QL (120 PER 30 DAYS) CLOZAPINE TAB 25MG ODT FAZACLO 3/1/ QL (270 PER 30 DAYS) COTELLIC TAB 20MG COBIMETINIB 3/1/ CYRAMZA INJ 100/10ML RAMUCIRUMAB 3/1/ CYRAMZA INJ 500/50ML RAMUCIRUMAB 3/1/ DARZALEX SOL 100MG/5M DARATUMUMAB 3/1/ DUTASTERIDE CAP 0.5MG AVODART 3/1/ QL (30 PER 30 DAYS) EMPLICITI INJ 300MG ELOTUZUMAB 3/1/ TACROLIMUS EXTENDED- ENVARSUS XR TAB 0.75MG RELEASE TABLETS 3/1/ ENVARSUS XR TAB 1MG TACROLIMUS EXTENDED- RELEASE TABLETS 3/1/ ENVARSUS XR TAB 4MG TACROLIMUS EXTENDED- RELEASE TABLETS 3/1/ FLUTICASONE SPR 50MCG FLONASE UPDATED 3/1/ QL (16 PER 25 DAYS) FOSCARNET INJ 24MG/ML FOSCARNET DELETION 3/1/
9 GENVOYA TAB ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE 3/1/ GLATOPA INJ 20MG/ML GLATIRAMER ACETATE 3/1/2016 2, QL (30 PER 30 DAYS) GLEOSTINE CAP 5MG LOMUSTINE 3/1/ IRESSA TAB 250MG GEFITINIB 3/1/ KEYTRUDA INJ 100MG/4M PEMBROLIZUMAB 3/1/ KLOR-CON 10 TAB 10MEQ ER POTASSIUM CHLORIDE 3/1/ KLOR-CON 8 TAB 8MEQ ER POTASSIUM CHLORIDE 3/1/ LANTUS INJ 100/ML INSULIN GLARGINE 3/1/ QL (30 PER 30 DAYS) LEVOTHYROXIN TAB 100MCG SYNTHROID 3/1/ LEVOTHYROXIN TAB 112MCG SYNTHROID 3/1/ LEVOTHYROXIN TAB 125MCG SYNTHROID 3/1/ LEVOTHYROXIN TAB 137MCG SYNTHROID 3/1/ LEVOTHYROXIN TAB 150MCG SYNTHROID 3/1/
10 LEVOTHYROXIN TAB 175MCG LEVOTHYROXIN TAB 200MCG LEVOTHYROXIN TAB 25MCG LEVOTHYROXIN TAB 300MCG LEVOTHYROXIN TAB 50MCG LEVOTHYROXIN TAB 75MCG LEVOTHYROXIN TAB 88MCG LONSURF TAB LONSURF TAB LYRICA CAP 100MG LYRICA CAP 150MG LYRICA CAP 200MG LYRICA CAP 225MG LYRICA CAP 25MG SYNTHROID 3/1/ SYNTHROID 3/1/ SYNTHROID 3/1/ SYNTHROID 3/1/ SYNTHROID 3/1/ SYNTHROID 3/1/ SYNTHROID 3/1/ TRIFLURIDINE AND TIPIRACIL 3/1/ TRIFLURIDINE AND TIPIRACIL 3/1/ /1/ /1/ /1/ /1/ /1/
11 LYRICA CAP 300MG 3/1/ LYRICA CAP 50MG 3/1/ LYRICA CAP 75MG 3/1/ LYRICA SOL 20MG/ML 3/1/ MEMANT TITRA PAK 5-10MG NAMENDA 3/1/ QL (60 PER 30 DAYS) MEMANTINE TAB HCL 10MG NAMENDA 3/1/ QL (60 PER 30 DAYS) MEMANTINE TAB HCL 5MG NAMENDA 3/1/ QL (60 PER 30 DAYS) MOLINDONE TAB HCL 10MG MOLINDONE 3/1/ MOLINDONE TAB HCL 25MG MOLINDONE 3/1/ MOLINDONE TAB HCL 5MG MOLINDONE 3/1/ MYCOPHENOLAT CAP 250MG CELLCEPT 3/1/ MYCOPHENOLAT SUS 200MG/ML CELLCEPT 3/1/ MYCOPHENOLAT TAB 500MG CELLCEPT 3/1/ NEUMEGA INJ 5MG OPRELVEKIN DELETION 3/1/ NEVIRAPINE TAB 100MG VIRAMUNE XR 3/1/ NINLARO CAP 2.3MG IXAZOMIB 3/1/2016 5, QL (21 PER 21 DAYS) 11
12 NINLARO CAP 3MG IXAZOMIB 3/1/ NINLARO CAP 4MG IXAZOMIB 3/1/ ODOMZO CAP 200MG SONIDEGIB 3/1/ OLOPATADINE SPR 0.6% PATANASE 3/1/ PALIPERIDONE TAB ER 1.5MG INVEGA 3/1/ QL (240 PER 30 DAYS) PALIPERIDONE TAB ER 3MG INVEGA 3/1/ QL (120 PER 30 DAYS) PALIPERIDONE TAB ER 6MG INVEGA 3/1/ QL (60 PER 30 DAYS) PALIPERIDONE TAB ER 9MG INVEGA 3/1/ QL (60 PER 30 DAYS) PHENYTOIN EX CAP 200MG DILANTIN DELETION 3/1/ PHENYTOIN EX CAP 300MG DILANTIN DELETION 3/1/ PIMOZIDE TAB 1MG ORAP 3/1/ PIMOZIDE TAB 2MG ORAP 3/1/ POT CHLORIDE CAP 10MEQ ER POTASSIUM CHLORIDE 3/1/ POT CHLORIDE CAP 8MEQ ER POTASSIUM CHLORIDE 3/1/ POT CHLORIDE LIQ 10% POTASSIUM CHLORIDE 3/1/ POT CHLORIDE LIQ 20% POTASSIUM CHLORIDE 3/1/ PREDNISOLONE SUS 1% OP PRED FORTE 3/1/ PREMARIN TAB 0.3MG CONJUGATED ESTROGENS 3/1/ PREMARIN TAB 0.45MG CONJUGATED ESTROGENS 3/1/ PREMARIN TAB 0.9MG CONJUGATED ESTROGENS 3/1/ PREMARIN TAB 1.25MG CONJUGATED ESTROGENS 3/1/
13 REXULTI TAB 0.25MG BREXPIPRAZOLE 3/1/ QL (480 PER 30 DAYS) REXULTI TAB 0.5MG BREXPIPRAZOLE 3/1/ QL (240 PER 30 DAYS) REXULTI TAB 1MG BREXPIPRAZOLE 3/1/ QL (120 PER 30 DAYS) REXULTI TAB 2MG BREXPIPRAZOLE 3/1/ QL (60 PER 30 DAYS) REXULTI TAB 3MG BREXPIPRAZOLE 3/1/ QL (30 PER 30 DAYS) REXULTI TAB 4MG BREXPIPRAZOLE 3/1/ QL (30 PER 30 DAYS) RIVASTIGMINE DIS 13.3/24 EXELON 3/1/ RIVASTIGMINE DIS 4.6MG/24 EXELON 3/1/ RIVASTIGMINE DIS 9.5MG/24 EXELON 3/1/ TAGRISSO TAB 40MG OSIMERTINIB 3/1/ TAGRISSO TAB 80MG OSIMERTINIB 3/1/ TANZEUM INJ 30MG ALBIGLUTIDE 3/1/ TANZEUM INJ 50MG ALBIGLUTIDE 3/1/ TESTOSTERONE GEL 1%(25MG) ANDROGEL 3/1/ QL (300 PER 30 DAYS) TESTOSTERONE GEL 1%(50MG) ANDROGEL 3/1/ QL (300 PER 30 DAYS) TETRABENAZIN TAB 12.5MG XENAZINE 3/1/ TETRABENAZIN TAB 25MG XENAZINE 3/1/ THIOTEPA INJ 15MG THIOTEPA 3/1/ XELJANZ TAB 5MG TOFACITINIB 3/1/
14 ALOSETRON TAB 0.5MG LOTRONEX 1/1/ ALOSETRON TAB 1MG LOTRONEX 1/1/ BEXAROTENE TARGRETIN 1/1/ GLATOPA INJ 20MG/ML COPAXONE 1/1/ LANTUS INJ 100/ML VIAL LEVOTHYROXINE TAB 25MCG LEVOTHYROXINE TAB 50MCG LEVOTHYROXINE TAB 75MCG LEVOTHYROXINE TAB 88MCG INSULIN GLARGINE LEVOTHYROXINE LEVOTHYROXINE LEVOTHYROXINE LEVOTHYROXINE LEVOTHYROXINE TAB 100MCG LEVOTHYROXINE LEVOTHYROXINE TAB 112MCG LEVOTHYROXINE LEVOTHYROXINE TAB 125MCG LEVOTHYROXINE LEVOTHYROXINE TAB 137MCG LEVOTHYROXINE, QL(60 per 30 days), QL(60 per 30 days) QL(30 per 30 days), 1/1/ QL (30 per 30 days) 14
15 LEVOTHYROXINE TAB 150MCG LEVOTHYROXINE LEVOTHYROXINE TAB 175MCG LEVOTHYROXINE LEVOTHYROXINE TAB 200MCG LEVOTHYROXINE LEVOTHYROXINE TAB 300MCG LEVOTHYROXINE KLOR-CON 8 TAB 8MEQ ER POTASSIUM CHLORIDE KLOR-CON 10 TAB 10MEQ ER POTASSIUM CHLORIDE KLOR-CON M20 TAB 20MEQ ER POTASSIUM CHLORIDE LYRICA CAP 25MG 1/1/ LYRICA CAP 50MG 1/1/ LYRICA CAP 75MG 1/1/ LYRICA CAP 100MG 1/1/ LYRICA CAP 225MG 1/1/ LYRICA CAP 300MG 1/1/ LYRICA SOL 20MG/ML 1/1/ MEMANTINE TAB HCL 5MG NAMENDA 1/1/ QL (60 per 30 days) 15
16 MEMANTINE TAB HCL 10MG NAMENDA 1/1/ QL (60 per 30 days) MEMANTINE TITRA PAK 5-10MG NAMENDA 1/1/ QL (60 per 30 days) PREMARIN TAB 0.3MG CONJUGATED ESTROGENS 1/1/ PREMARIN TAB 0.45MG CONJUGATED ESTROGENS 1/1/ PREMARIN TAB 0.9MG CONJUGATED ESTROGENS 1/1/ PREMARIN TAB 1.25MG CONJUGATED ESTROGENS 1/1/ XELJANZ TAB 5MG TOFACITINIB 1/1/
17 17
18 18
Medicare Part D 2016 Formulary Changes Service To Senior and OC Preferred
Medicare Part D 2016 Formulary s Service To Senior and OC Preferred Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior
Medicare Part D 2016 Formulary Changes Desert Preferred Choice
Medicare Part D 2016 Formulary s Desert Preferred Choice Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization,
2016 Medicare Part D Formulary Change
2016 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy
August 2016 Formulary Updates
August 2016 Formulary Updates DOXYCYCLINE HYCLATE TABS DR 50MG, 200MG NALOXONE HCL INJ 0.4MG/ML VANCOMYCIN HCL INJ 500MG, 750MG BRIVIACT INJ - PA BRIVIACT ORAL SOLN - QL; PA BRIVIACT TABS - QL; PA LENVIMA
Aetna Better Health Illinois Premier Plan. November 2015 Formulary Updates. October 2015 Formulary Updates
Aetna Better Health Illinois Premier Plan November 2015 Formulary Updates desogestrel & ethinyl estradiol tab 0.15 mg-30 mcg RIVASTIGMINE DIS 13.3/24; QL (30 patches/30 days) RIVASTIGMINE DIS 4.6MG/24;
December 2016 Formulary Updates
December 2016 Formulary Updates ABACAVIR/LAMIVUDINE AMLODIPINE/OLMESARTAN MEDOXOMIL TAB 10-20MG QL AMLODIPINE/OLMESARTAN MEDOXOMIL TAB 10-40MG QL AMLODIPINE/OLMESARTAN MEDOXOMIL TAB 5-20MG QL AMLODIPINE/OLMESARTAN
November 2016 Formulary Updates
November 2016 Formulary Updates DAPTOMYCIN LARISSIA NITROGLYCERIN SUBL ORFADIN 20MG CAP PA RELISTOR 150MG TAB PA; QL Over-the-Counter (OTC) Drugs Added* COLEMAN SKINSMART INSECT REP CUTTER BACKWOODS AERO
December 2016 Formulary Updates
December 2016 Formulary Updates ABACAVIR/LAMIVUDINE AMLODIPINE/OLMESARTAN MEDOXOMIL TAB 10-20MG QL AMLODIPINE/OLMESARTAN MEDOXOMIL TAB 10-40MG QL AMLODIPINE/OLMESARTAN MEDOXOMIL TAB 5-20MG QL AMLODIPINE/OLMESARTAN
Aetna Better Health FIDA Plan
Aetna Better Health FIDA Plan May 2016 Formulary Updates ASCOMP/COD - QL; PA FYAVOLV 5MCG; 1MG- PA METOPROLOL TABS 37.5MG, 75MG CIPRODEX LETAIRIS - QL; PA OFEV - QL; PA OTREXUP - ST PRALUENT - QL; PA RASUVO
Network Health Insurance Corporation Upcoming Negative Changes to the Medicare Part D Formulary
Requesting an Exception to the Formulary You can ask Network Health Insurance Corporation to make an exception to our coverage rules. Generally, we will only approve your request for an exception if alternative
Medicare Part D 2012 Formulary Changes Service To Senior and Total Fit
Medicare Part D 2012 Formulary s Service To Senior and Total Fit Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization,
Formulary Change Notice
Formulary Change Notice HealthPartners may remove drugs from our formulary (list of covered drugs) or add rules about whether and when certain drugs are covered during the year. The chart below contains
ate Formulary Upda ). We are open: October 1 February 8 a.m. 8 a.m. February drugs: You ask us to pay Formulary attached If you
MEDICARE ADVANTAGE HealthNow New York Formulary Upda ate Please note, the HealthNow New York Formulary has been updated since its original printing in September, 2015. This insert outlines all of the updates
ALLERGIC CONJUNCTIVITIS AGENTS
2018 5 Tier Standard- Keystone First VIP Choice Document: 2018 Step Therapy Formulary ID: 18390 Last Updated: 04/2018 Effective Date: 05-01-2018 ALLERGIC CONJUNCTIVITIS AGENTS epinastine 0.05 % eye drops
Medicare Part D 2015 Formulary Changes Desert Preferred Choice
Medicare Part D 2015 Formulary s Desert Preferred Choice Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization,
Medicare Part D 2017 Formulary Changes OC Preferred
Medicare Part D 2017 Formulary Changes OC Preferred Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization,
ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY
South Country Health Alliance 2017 Step Therapy Formulary ID: 17431 Last Updated: 10/20/2017 Effective Date: 11-01-2017 ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY BENICAR 20 MG BENICAR 40 MG BENICAR 5
Medicare Part D 2017 Formulary Changes Service To Senior
Medicare Part D 2017 Formulary s Service To Senior Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization,
You can win a Pizza Party for your office!
You can win a Pizza Party for your office! Geeta Patwa, MD and her staff from Chaparral Medical Group were the winners of the last InfoLink Pizza Party. IMPROVING QUALITY OF LIFE: INTER VALLEY FOCUSES
2017 Step Therapy Criteria
FRESENIUS TOTAL HEALTH 2017 Step Therapy Updated 07/01/2017. For more recent information or other questions, please contact Fresenius Total Health Customer Service at 1-855-598-6774 / TTY 1-844-209-9094.
2016 FORMULARY ADDENDUM NOTICE OF CHANGE
2016 FORMULARY ADDENDUM NOTICE OF CHANGE (PRESCRIPTION DRUG PLANS) WELLCARE PRESCRIPTION INSURANCE, INC. WellCare Simple (PDP) WellCare Classic (PDP) WellCare Extra (PDP) This is a listing of the changes
TEST ANTICONVULSANT THERAPY. Products Affected. Step 2: Network Health Insurance Corporation NetworkCares Step Therapy Criteria Last Updated 11/2018
TEST Network Health Insurance Corporation NetworkCares Step Therapy Last Updated 11/2018 ANTICONVULSANT THERAPY Aptiom Banzel Briviact Celontin Dilantin 30 Mg Capsule Equetro Fycompa 0.5 Mg/ml Oral Susp
Health Partners Medicare Prime 2019 Formulary Changes
Health Partners Medicare Prime 2019 Formulary Changes Changes occur, for example, because new drugs come on the market, a drug is moved to a different cost-sharing level (tier), or a generic version becomes
Medicare Part D 2017 Formulary Changes OC Preferred
Medicare Part D 2017 Formulary s OC Preferred Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization, quantity
Pharmacy and Therapeutics (P&T) Committee Provider Update
Pharmacy and Therapeutics (P&T) Committee Provider Update THIRD QUARTER 2018 P&T Committee Decisions Effective September 1, 2018 Dear Healthcare Practitioner: The Presbyterian Health Plan, Inc., and Presbyterian
Medicare Part D 2017 Formulary Changes OC Preferred
Medicare Part D 017 Formulary s OC Preferred Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization, quantity
New Generics: Specialty Network: Retail Pharmacies Dispensing Specialty Products
SUPPORTING OUR PROVIDER PARTNERS THROUGH COMMUNICATION AND COLLABORATION. DATE JANUARY 2016 ISSUE 1 HELPFUL NUMBERS FOR PROVIDERS Magellan: 1-800-846-7971 Bin: 016523 Processor control: 747 HELPFUL NUMBERS
2018 Formulary Notice of Change Prescription Drug Plans
2018 Formulary Notice of Change Prescription Drug Plans WellCare Prescription Insurance, Inc. Plans in all states: WellCare Classic (PDP) WellCare may add or remove drugs from our formulary during the
Quarterly pharmacy formulary change notice
Quarterly pharmacy formulary change notice Summary of change: The Pharmacy and Therapeutics Committee (P&T) reviewed and approved the formulary changes listed in the table below on March 29, 2016. What
Antipsychotics Prior Authorization Criteria for Louisiana Fee for Service and MCO Medicaid Recipients
Antipsychotics Prior Authorization Criteria for Louisiana Fee for Service and MCO Medicaid Recipients Preferred Agents (Oral) a Amitriptyline/Perphenazine (Generic) Aripiprazole Tablet (Generic) b Chlorpromazine
Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies
Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies BlueCross BlueShield of South Carolina may add or remove drugs from the formulary during the year. If we remove drugs
Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18
Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18 Granite Alliance requires step therapy for certain drugs. This means prior to receiving a drug with a step therapy
SecureBlue Formulary 2016 Master Negative Changes from 2015 to 2016
Beta-lactam, SUPRAX TAB 400MG Suprax 400 mg cap Antibacterials Cephalosporins Beta-lactam, CEFOTAXIME INJ 10GM cefotaxime 2 gm inj Antibacterials Cephalosporins ERYTHROCIN INJ 1000MG Erythrocin 500 mg
Superior Select Health Plans: Tribute-1 Tier May 2018 Formulary Addendum
Superior Select Health Plans: Tribute-1 Tier May 2018 Formulary Addendum Below is a list formulary changes for the benefit year 2018. This is not a complete list of drugs covered by the Part D plan. The
Presbyterian Health Plan, Inc. Presbyterian Insurance Company, Inc. NOTIFICATION OF FORMULARY CHANGES
NOTIFICATION OF FORMULARY CHANGES The following summary describes changes to the Presbyterian Commercial Large Group Plans (Non-Metal Plans) Formularies effective 2018. For the most recent list of drugs,
ANTICONVULSANT STEP THERAPY
2019 First Choice VIP Care Plus Formulary Document: 2019 Step Therapy Formulary ID: 19391 Last Updated: 2/2019 Effective Date: 03-01-2019 ANTICONVULSANT STEP THERAPY APTIOM 200 MG APTIOM 400 MG APTIOM
Drug Name Description of Change Formulary Coverage Formulary Alternative(s)
NOTIFICATION OF FORMULARY CHANGES The following summary describes changes to the Presbyterian Centennial Care Formulary effective 2018. For the most recent list of drugs, information on asking for a prior
NOTIFICATION OF FORMULARY CHANGES
NOTIFICATION OF CHANGES The following summary describes changes to the 2018 Presbyterian Senior Care (HMO)/(HMO-POS), Presbyterian MediCare PPO and formularies. The formulary may change at any time. You
Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates
Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates July 2018 TRADE NAME (generic name) or generic name ADVAIR DISKUS (fluticasone-salmeterol aer powder ba 100-50 mcg/dose) Brand Addition ADVAIR
Presbyterian Health Plan, Inc. Presbyterian Insurance Company, Inc. NOTIFICATION OF FORMULARY CHANGES
NOTIFICATION OF FORMULARY CHANGES The following summary describes changes to the 2017 Presbyterian Individual and Family Metal Plan/Employer Group Metal Plan Formularies effective 2018. For the most recent
September 2018 Pharmacy & Therapeutics Committee Decisions
UCare s Pharmacy and Therapeutics Committee (P&T) is a group of physicians and pharmacists that meet throughout the year to make changes to UCare (approved drug list). These changes are reviewed based
Pharmacy Medical Necessity Guidelines: Antipsychotic Medications
Pharmacy Medical Necessity Guidelines: Effective: April 1, 2018 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy (RX) or Medical (MED) Benefit
AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details
AMANTADINE ER OSMOLEX ER 129 MG, EXTENDED RELEASE OSMOLEX ER 193 MG, EXTENDED RELEASE OSMOLEX ER 258 MG, EXTENDED RELEASE PRIOR CLAIM FOR AMANTADINE HCL IMMEDIATE RELEASE WITHIN THE PAST 120 DAYS. 1 ANTICONVULSANTS
ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR
ABILIFY INJ ABILIFY MAINTENA PREFILLED SYRINGE 300 MG ABILIFY MAINTENA PREFILLED SYRINGE 400 MG ABILIFY MAINTENA SUSPENSION RECONSTITUTED ER 300 MG Claim will pay automatically for ABILIFY MAINTENA if
Memorial Hermann Advantage HMO February 2019 Formulary Addendum
Memorial Hermann Advantage HMO February 2019 Formulary Addendum Changes may have occurred since the printing of your current Memorial Hermann Advantage HMO Formulary. Medications that may have been added
Aetna Better Health of Illinois Medicaid Formulary Updates
October 2017 o DOXYLAMINE SUCCINATE 25mg-QL o DULOXETINE CAP 40MG DR-QL o GUANFACIN ER TABS (all strengths)-ql o TOBRAMYCIN NEBU SOLUTION- PA August 2017 Aetna Better Health of Illinois Medicaid 2017 Formulary
Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria
Drug/Drug Class Antipsychotics Clinical Criteria Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria Prior
FirstCarolinaCare Insurance Company. Step Therapy Requirements
FirstCarolinaCare Insurance Company Step Therapy Requirements Effective: 12/01/2018 ANTICONVULSANTS APTIOM 200 MG APTIOM 400 MG APTIOM 600 MG APTIOM 800 MG BANZEL 200 MG BANZEL 40 MG/ML ORAL SUSPENSION
Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E
Santa Clara Family Health Plan Cal MediConnect Formulary List of Step Therapy Requirements Effective: 12/01/2018 13027.12E ANTICONVULSANTS APTIOM 200 MG TABLET APTIOM 400 MG TABLET APTIOM 600 MG TABLET
Quarterly pharmacy formulary change notice
Provider Bulletin June 24, 2016 Summary of change The Pharmacy and Therapeutics Committee reviewed and approved the formulary changes listed in the table below on March 29, 2016. What this means to you
ANTICONVULSANTS. Details
ANTICONVULSANTS Aptiom 200 mg tablet Aptiom 400 mg tablet Aptiom 600 mg tablet Aptiom 800 mg tablet Banzel 200 mg tablet Banzel 40 mg/ml oral suspension Banzel 400 mg tablet Fycompa 0.5 mg/ml oral suspension
Step Therapy Requirements. Effective: 1/1/2019
Effective: 1/1/2019 Updated 1/2019 AMANTADINE ER Sharp Health Plan (HMO) OSMOLEX ER 129 MG, EXTENDED RELEASE OSMOLEX ER 193 MG, EXTENDED RELEASE OSMOLEX ER 258 MG, EXTENDED RELEASE PRIOR CLAIM FOR AMANTADINE
Pharmacy Medical Necessity Guidelines: Antipsychotic Medications
Pharmacy Medical Necessity Guidelines: Effective: October 1, 2016 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy (RX) or Medical (MED) Benefit
2018 Formulary Update
MEDICARE ADVANTAGE BlueShield of Northeastern New York 2018 Formulary Update BlueShield of Northeastern New York has updated its formulary (drug list) since its original publication in January 2018. This
ANTICONVULSANT THERAPY
Network Health Insurance Corporation NetworkCares Step Therapy Last Updated: 7/2017 ANTICONVULSANT THERAPY Aptiom 200 mg tablet Aptiom 400 mg tablet Aptiom 600 mg tablet Aptiom 800 mg tablet Banzel 200
Step Therapy Requirements
Step Therapy Requirements Denver Health Medicare Choice (HMO SNP)/Medicare Select (HMO) Effective: 09/01/2017 Updated 08/2017 ANTICONVULSANTS Aptiom 200 mg tablet Aptiom 400 mg tablet Aptiom 600 mg tablet
ANTICONVULSANTS. Details. Step Therapy Criteria Date Effective: April 1, 2019
Step Therapy Date Effective: April 1, 2019 ANTICONVULSANTS APTIOM TABLET 200 MG ORAL APTIOM TABLET 400 MG ORAL APTIOM TABLET 600 MG ORAL APTIOM TABLET 800 MG ORAL BANZEL SUSPENSION 40 MG/ML ORAL BANZEL
Step Therapy Group. Atypical Antipsychotic Agents
Atypical Antipsychotic Agents Any beneficiary newly enrolled into Community Care, Inc. currently receiving aripiprazole, aripiprazole ODT, risperidone, risperidone ODT, olanzapine, olanzapine ODT, quetiapine,
AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details
AMANTADINE ER OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, EXTENDED RELEASE OSMOLEX ER 258 MG TABLET, PRIOR CLAIM FOR AMANTADINE HCL IMMEDIATE RELEASE WITHIN THE PAST 120 DAYS.
ANTICONVULSANTS. Details
ANTICONVULSANTS APTIOM 200 MG TABLET APTIOM 400 MG TABLET APTIOM 600 MG TABLET APTIOM 800 MG TABLET BANZEL 200 MG TABLET BANZEL 40 MG/ML ORAL SUSPENSION BANZEL 400 MG TABLET FYCOMPA 0.5 MG/ML ORAL SUSPENSION
AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details
AMANTADINE ER OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, EXTENDED RELEASE OSMOLEX ER 258 MG TABLET, PRIOR CLAIM FOR AMANTADINE HCL IMMEDIATE RELEASE WITHIN THE PAST 120 DAYS.
ANTICONVULSANTS. Details
ANTICONVULSANTS Aptiom 200 mg tablet Aptiom 400 mg tablet Aptiom 600 mg tablet Aptiom 800 mg tablet Banzel 200 mg tablet Banzel 40 mg/ml oral suspension Banzel 400 mg tablet Fycompa 0.5 mg/ml oral suspension
2018 Medicare Part D Formulary Change
2018 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy
January 2018 Pharmacy & Therapeutics Committee Decisions
UCare s Pharmacy and Therapeutics Committee (P&T) is a group of physicians and pharmacists that meet throughout the year to make changes to the UCare formulary (approved drug list). These changes are reviewed
VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017
VNSNY CHOICE FIDA Complete Step Therapy Requirements Effective: 01/01/2017 Updated 12/23/2016 ANTICONVULSANTS Aptiom 200 mg tablet Potiga 200 mg tablet Aptiom 400 mg tablet Potiga 300 mg tablet Aptiom
Clinical Therapeutic Intelligence Report: 2015 Year in Review
Clinical Therapeutic Intelligence Report: 2015 Year in Review This issue highlights the many ground-breaking therapies approved by the U.S. Food and Drug Administration over the course of 2015. Highlights
Quarterly pharmacy formulary change notice
The formulary changes listed in the table below apply to all Anthem HealthKeepers Plus and Anthem HealthKeepers Plus, Commonwealth Coordinated Care Plus (Anthem CCC Plus) members. These formulary changes,
VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 04/01/2019
VNSNY CHOICE FIDA Complete Step Therapy Requirements Effective: 04/01/2019 Updated 03/2019 AMANTADINE ER OSMOLEX ER 129 MG, EXTENDED RELEASE OSMOLEX ER 193 MG, EXTENDED RELEASE OSMOLEX ER 258 MG, EXTENDED
FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS
FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS DHMC/CHP+ may add or remove drugs from the formulary or make changes to restrictions on formulary drugs
ANTICONVULSANTS. Details
ANTICONVULSANTS APTIOM 200 MG APTIOM 400 MG APTIOM 600 MG APTIOM 800 MG BANZEL 200 MG BANZEL 40 MG/ML ORAL SUSPENSION BANZEL 400 MG FYCOMPA 0.5 MG/ML ORAL SUSPENSION FYCOMPA 10 MG FYCOMPA 12 MG FYCOMPA
2018 Drug List Negative Changes Updated 10/25/2018 The table below shows changes made to our 2018 List of Covered Drugs (Formulary).
2018 Drug List Negative s Updated 10/25/2018 The table below shows changes made to our 2018 List of Covered Drugs (Formulary). Date of 1/1/2018 COLYTE-FLAVOR PACKS SOLR 227.1GM- 21.5GM-5.53GM- 2.82GM-6.36GM
Drug Pipeline Update
CLINICAL SOLUTIONS Drug Insights > December 2015 Drug Pipeline Update New Drug Information Narcan (naloxone): Adapt Pharma and Lightlake Therapeutics received Food and Drug Administration (FDA) approval
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select April 1, 2018 Updates Drug Name adapalene-benzoyl-peroxide Gel 0.1-2.5% (Brand = Epiduo ) prasugrel hcl (Brand = Effient ) vigabatrin pak 500 mg (Brand
Medicare Part D 2017 Formulary Changes Service To Senior
Medicare Part D 2017 Formulary Changes Service To Senior Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization,
Health Partners Medicare Special 2018 Formulary Changes
Health Partners Medicare Special 2018 Changes Changes occur, for example, because new drugs come on the market, a drug is moved to a different cost-sharing level (tier), or a generic version becomes available.
FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS
FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS DHMC/CHP+ may add or remove drugs from the formulary or make changes to restrictions on formulary drugs
VIVA MEDICARE IMPORTANT T EXPANDED PERFORMANCE FORMULARY UPDATES
NORE/ETH/FER CHW 0.MG Added to the 07 //07 ALYACEN TAB / Added to the 07 //07 AMETHIA LO TAB Added to the 07 //07 ERGOT/CAFFEN TAB 00MG Added to the 07 //07 NORETH/ETHIN TAB /0 Added to the 07 //07 LORCET
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select April 1, 2018 Updates Drug Name adapalene-benzoyl-peroxide Gel 0.1-2.5% (Brand = Epiduo ) prasugrel hcl (Brand = Effient ) vigabatrin pak 500 mg (Brand
Pharmacy Benefit Management (PBM) Program FORMULARY/PRODUCT RESTRICTIONS
Workforce Safety & Insurance Revised Document Date: 07/21/2015 1600 E Century Ave Ste 1 PO Box 5585 Bismarck, ND 58506-5585 701.328.3800 1.800.777.5033 www.workforcesafety.com Pharmacy Benefit Management
2018 CareOregon Advantage Part D Formulary Changes
2018 CareOregon Advantage Part D Formulary Changes Abbreviations: AGE = Age Restriction; PA = Prior Authorization Required; QL = Quantity Limit; ST = Step Therapy Required; LD = Limited Distribution; BvD
Step Therapy Requirements. Effective: 11/01/2018
Effective: 11/01/2018 Updated 10/2018 ANTIDEPRESSANTS Sharp Health Plan (HMO) TRINTELLIX 10 MG TABLET TRINTELLIX 20 MG TABLET TRINTELLIX 5 MG TABLET VIIBRYD 10 MG (7)-20 MG (23) TABLETS IN A DOSE PACK
VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017
Effective: 01/01/2017 Updated 11/2016 ANTI-INFLAMMATORY AGENTS - GI DIPENTUM PRIOR CLAIM FOR BALSALAZIDE OR APRISO WITHIN THE PAST 120 DAYS. ANTICONVULSANTS APTIOM BANZEL FYCOMPA GABITRIL OXTELLAR XR POTIGA
2017 Formulary (List of Covered Drugs)
Enhanced 2017 Formulary (List of Covered Drugs) HPMS Approved Formulary File Submission ID 17121, Version Number 15 This document contains information about the drugs we cover in this plan. For more recent
PRECISION CANCER MEDICINE DR. VANESSA DICKEY TORRANCE MEMORIAL PHYSICIAN NETWORK CANCER CARE ASSOCIATES
PRECISION CANCER MEDICINE DR. VANESSA DICKEY TORRANCE MEMORIAL PHYSICIAN NETWORK CANCER CARE ASSOCIATES REAL PATIENT; ANN (ALIAS) 63 year old woman who smoked for 25 years, quit 15 years ago. Complained
Beneficiary Advisory Panel Handout Uniform Formulary Decisions 23 June 2011
Beneficiary Advisory Panel Handout Uniform Formulary Decisions 23 June 211 PURPOSE: The purpose of this handout is to provide BAP Committee members with a reference document for the relative clinical effectiveness
May 2017 P&T Updates
May 2017 P&T Updates Commercial Triple Tier 4th Tier Applicable Traditional Prior Auth Alternatives 6 ml per AMPYRA 3 2 2 tablets per day, 30 day BYDUREON 3 2 4 vials per 28 days 5 mcg pen: 1.2 ml per
ANTIDIABETIC AGENTS - MISCELLANEOUS
ANTIDIABETIC AGENTS - MISCELLANEOUS Glyxambi 10 mg-5 mg tablet Glyxambi 25 mg-5 mg tablet Invokamet 150 mg-1,000 mg tablet Invokamet 150 mg-500 mg tablet Invokamet 50 mg-1,000 mg tablet Invokamet 50 mg-500
**CRITERIA UNDER CMS REVIEW**
**CRITERIA UNDER CMS REVIEW** ANTICONVULSANTS APTIOM TABLET 200 MG APTIOM TABLET 400 MG APTIOM TABLET 600 MG APTIOM TABLET 800 MG BANZEL SUSPENSION 40 MG/ML BANZEL TABLET 200 MG BANZEL TABLET 400 MG BRIVIACT
ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria
ANTIDEPRESSANTS Trintellix 10 mg tablet Trintellix 20 mg tablet Trintellix 5 mg tablet Viibryd 10 mg (7)-20 mg (23) tablets in a dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet
2014 Quantity Limits (QL) Criteria
2014 Quantity Limits (QL) Criteria Certain drugs covered through your EmblemHealth Medicare HMO/PPO Medicare Plan are covered for only a limited quantity. We do this to ensure compliance with the US Food
PHARMACY AND THERAPEUTICS COMMITTEE 4 th Quarter 2017
PHARMACY AND THERAPEUTICS COMMITTEE 4 th Quarter 2017 A meeting of the Health Partners Pharmacy and Therapeutics (P&T) Committee was held on September and December 2017. The following are the recommendations
ANTIDIABETIC AGENTS - MISCELLANEOUS
ANTIDIABETIC AGENTS - MISCELLANEOUS Glyxambi 10 mg-5 mg tablet Glyxambi 25 mg-5 mg tablet Invokamet 150 mg-1,000 mg tablet Invokamet 150 mg-500 mg tablet Invokamet 50 mg-1,000 mg tablet Invokamet 50 mg-500